Essentials - Assessment and Management of Tobacco Use Disorders-Event Handout

Event Handout

Pdf Summary

This document is a summary of the key points discussed in the content titled "AOAAM Essentials in Addiction Medicine: Assessment and Management of Tobacco Use Disorders." <br /><br />The document covers various aspects related to tobacco use disorder, including its diagnostic criteria, the history of tobacco, its impact on health, assessment instruments, behavioral change, and common forms of treatment. <br /><br />It is mentioned that tobacco use disorder is diagnosed based on the DSM-5 criteria, which include criteria related to consumption of larger quantities of tobacco than intended, unsuccessful efforts to quit or reduce intake, cravings for tobacco, and continued use despite adverse consequences. <br /><br />Statistics regarding tobacco use are also provided, highlighting its status as the number one preventable cause of disease, disability, and death in the United States. It is estimated that over 16 million Americans suffer from smoking-related diseases and that secondhand smoke exposure is responsible for the deaths of thousands of nonsmokers each year. <br /><br />Various intervention strategies are discussed in the document, including policy interventions such as taxation, smoke-free legislation, and health warning labels, as well as clinical interventions such as stage of change-based interventions and pharmacotherapy. <br /><br />The document also addresses the co-occurrence of tobacco use disorder with other substance use disorders and mental illnesses. It highlights the high rates of smoking among individuals with alcohol use disorders, illicit drug users, and those with mental illnesses. <br /><br />The CDC's recommendations for the management of tobacco use disorder are mentioned, which include screening patients for tobacco use, advising them to quit, offering cessation medication and counseling, and arranging follow-up contact. <br /><br />The document concludes by discussing the chronic and relapsing nature of tobacco use disorder, the success rates of quitting attempts without formal treatment, the importance of intensity in counseling, and the use of pharmacotherapy in management. It also provides information on various nicotine replacement therapies, such as gum, lozenges, patches, inhalers, and nasal sprays, as well as medications like bupropion and varenicline. <br /><br />Overall, the document provides a comprehensive overview of the assessment and management of tobacco use disorders, highlighting the importance of addressing this preventable condition to improve public health.

Keywords

Tobacco use disorder

DSM-5 criteria

Impact on health

Intervention strategies

Co-occurrence

Substance use disorders

Mental illnesses

CDC's recommendations

Nicotine replacement therapies

Public health